FGF21 and metabolic dysfunction-associated steatotic liver disease: Furthermore, induction of FOXA1 is an adaptive response to hepatic steatosis and was shown to reduce lipid accumulation in human hepatocytes [39] as is the induction of FGF21 with its great therapeutic potential in the treatment of NAFLD [40].